NTLA Competitors & Alternatives
Compare Intellia Therapeutics Inc with similar stocks in the same industry
Biotechnology
NTLA
Main Stock$13.09
Tradestie Score
50
Market Cap
$2.01B
Revenue Growth
-0.1%
Analyst Upside
+102.8%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$34.19
|
$1.97B | - | 57 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.50
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$134.72
|
$1.92B | - | 58 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$59.30
|
$1.90B | 338.8 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$39.56
|
$1.84B | - | 51 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.76
|
$1.81B | - | 59 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$4.40
|
$1.78B | - | 59 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$18.28
|
$1.78B | - | 57 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$52.95
|
$1.77B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.43
|
$1.74B | - | 57 | Compare |
More NTLA Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2835)
233 stocks in this industry